Carl M Bosch - Net Worth and Insider Trading

Carl M Bosch Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Carl M Bosch owns 1 companies in total, including Navidea Biopharmaceuticals Inc (NAVB) .

Click here to see the complete history of Carl M Bosch’s form 4 insider trades.

Insider Ownership Summary of Carl M Bosch

Ticker Comapny Transaction Date Type of Owner
NAVB Navidea Biopharmaceuticals Inc 2004-01-07 VP - Instrument Development

Carl M Bosch Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Carl M Bosch Ownership Network

Ownership Network List of Carl M Bosch

No Data

Ownership Network Relation of Carl M Bosch

Insider Network Chart

Carl M Bosch Owned Company Details

What does Navidea Biopharmaceuticals Inc do?

Who are the key executives at Navidea Biopharmaceuticals Inc?

Carl M Bosch is the VP - Instrument Development of Navidea Biopharmaceuticals Inc. Other key executives at Navidea Biopharmaceuticals Inc include Chief Financial Officer Craig Dais , director & 10 percent owner Scott John K Jr. , and Chief Regulatory Officer Michel Mikhail .

Navidea Biopharmaceuticals Inc (NAVB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Navidea Biopharmaceuticals Inc (NAVB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Navidea Biopharmaceuticals Inc (NAVB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Navidea Biopharmaceuticals Inc (NAVB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Navidea Biopharmaceuticals Inc Insider Transactions

No Available Data

Carl M Bosch Mailing Address

Above is the net worth, insider trading, and ownership report for Carl M Bosch. You might contact Carl M Bosch via mailing address: 425 Metro Place North, Ste 400, Dublin Oh 43017.

Discussions on Carl M Bosch

No discussions yet.